Skip to content

   Pharma Publications

Neuropsychopharmacology
  • FGF21 analogue PF-05231023 on alcohol consumption and neuronal activity in the nucleus accumbens
    Published on 2025-05-26
    1 year ago
  • Cortical myelin mapping in antipsychotic medication-naïve, first-episode psychosis patients
    Published on 2025-05-23
    1 year ago
  • The Tailtag: A multi-mouse tracking system to measure social dynamics in complex environments
    Published on 2025-05-22
    1 year ago
  • DLPFC: The Decade circLe CCNP Family Cohort
    Published on 2025-05-21
    1 year ago
  • Stress-related genetic factors modify the effect of socioeconomic status on cardiovascular risk
    Published on 2025-05-21
    1 year ago
  • Sleep patterns predicting stress resilience are dependent on sex
    Published on 2025-05-17
    1 year ago
  • The efficacy of elevating anandamide via inhibition of fatty acid amide hydrolase (FAAH) combined with internet-delivered cognitive behavioral therapy in the treatment of post-traumatic stress disorder: a randomized, placebo-controlled clinical trial
    Published on 2025-05-17
    1 year ago
« Previous 1 … 44 45 46 47 48 … 143 Next »
Journal of Psychopharmacology
  • Aripiprazole for treating delirium: A systematic review—Is it a valid yet understudied treatment?
    Published on 2024-04-30
    2 years ago
  • Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice
    Published on 2024-04-29
    2 years ago
  • Unveiling potential adverse events associated with escitalopram oxalate: A real-world analysis based FDA adverse event reporting system database
    Published on 2024-04-28
    2 years ago
  • The trace amine-associated receptor 1 agonists – non-dopaminergic antipsychotics or covert modulators of D2 receptors?
    Published on 2024-04-24
    2 years ago
  • Exploring psychedelic-assisted therapy in the treatment of functional seizures: A review of underlying mechanisms and associated brain networks
    Published on 2024-04-24
    2 years ago
  • Influence of GABAA and GABAB receptor activation on auditory sensory gating and its association with anxiety in healthy volunteers
    Published on 2024-04-22
    2 years ago
  • Mining and analysis of security alert signals of valbenazine based on the Food and Drug Administration Adverse Event Reporting System database
    Published on 2024-04-20
    2 years ago
« Previous 1 … 44 45 46 47 48 … 145 Next »
European Neuropsychopharmacology
  • Lithium versus anticonvulsants and the risk of physical disorders – Results from a comprehensive long-term nation-wide population-based study emulating a target trial
    Published on 2024-04-25
    2 years ago
  • Sex representation in mental health research
    Published on 2024-04-24
    2 years ago
  • Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
    Published on 2024-04-24
    2 years ago
  • Challenges in testing concentrated cognitive-behaviour therapy for unmedicated adults with obsessive-compulsive disorder in routine care
    Published on 2024-04-21
    2 years ago
  • Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents
    Published on 2024-04-21
    2 years ago
  • Taking uncertainty in the assessment of response into account: An advanced guideline for computing responder rates in clinical trials
    Published on 2024-04-21
    2 years ago
  • Schizophrenia patients are not benefiting from worldwide improvements in life expectancy
    Published on 2024-04-21
    2 years ago
« Previous 1 … 44 45 46 47 48 … 166 Next »

   Pharma Pub